CXMT's IPO on China's STAR Market will reignite market enthusiasm and open investment opportunities. CXMT is the only Chinese company developing HBM3 and above, and upon listing it will likely become the largest market-cap stock on the Sci-Tech Innovation Board. Direct foreign retail access is restricted, but STAR Market ETFs offer a viable vehicle. The speaker has been actively recommending investing in the STAR Market specifically because of the CXMT catalyst, anticipating a significant revival in board activity.